Myelin News and Research RSS Feed - Myelin News and Research

Myelin is the fatty substance that covers and protects nerves.
Scientists one step closer to creating viable cell replacement therapy for multiple sclerosis patients

Scientists one step closer to creating viable cell replacement therapy for multiple sclerosis patients

Scientists at The New York Stem Cell Foundation Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient's own cells. [More]
Elevated ASM activity linked to Alzheimer's disease

Elevated ASM activity linked to Alzheimer's disease

Unclogging the body's protein disposal system may improve memory in patients with Alzheimer's disease (AD), according to a study from scientists at Kyungpook National University in Korea published in The Journal of Experimental Medicine. [More]
Study: L-carnitine has neuroprotective effects on injured sciatic nerve of rats

Study: L-carnitine has neuroprotective effects on injured sciatic nerve of rats

Several studies have demonstrated that L-carnitine exhibits neuroprotective effects on injured sciatic nerve of rats with diabetes mellitus. [More]
Scientists identify novel approach to treating multiple sclerosis

Scientists identify novel approach to treating multiple sclerosis

Scientists in the University of Connecticut's Technology Incubation Program have identified a novel approach to treating multiple sclerosis (MS) using human embryonic stem cells, offering a promising new therapy for more than 2.3 million people suffering from the debilitating disease. [More]
Dendrimer offers a simple way of creating vesicles

Dendrimer offers a simple way of creating vesicles

One of the defining features of cells is their membranes. Each cell's repository of DNA and protein-making machinery must be kept stable and secure from invaders and toxins. Scientists have attempted to replicate these properties, but, despite decades of research, even the most basic membrane structures, known as vesicles, still face many problems when made in the lab. They are difficult to make at consistent sizes and lack the stability of their biological counterparts. [More]
About MS booklet now available as a printed and online publication

About MS booklet now available as a printed and online publication

The Multiple Sclerosis Association of America is pleased to announce that the newly published About MS booklet is now available as both a printed and online publication. [More]
Oligodendrocyte lineage gene 1 plays key role in hypoxic-ischemic brain damage

Oligodendrocyte lineage gene 1 plays key role in hypoxic-ischemic brain damage

... [More]
Harvard neuroscientists present new view of myelin

Harvard neuroscientists present new view of myelin

Harvard neuroscientists have made a discovery that turns 160 years of neuroanatomy on its head. [More]
U.Va. researchers named recipients of 2013 Hartwell Individual Biomedical Research Awards

U.Va. researchers named recipients of 2013 Hartwell Individual Biomedical Research Awards

University of Virginia neurologist Dr. Erin Pennock Foff, biologist Sarah Kucenas and biomedical engineer Shayn Peirce-Cotter have been named recipients of 2013 Hartwell Individual Biomedical Research Awards to benefit children of the United States. Each scientist will receive $100,000 in direct annual research support from The Hartwell Foundation for three years. [More]
Researcher wins 2014 Abraham White Distinguished Science Award for contributions in treatment of neurological diseases

Researcher wins 2014 Abraham White Distinguished Science Award for contributions in treatment of neurological diseases

Michael Chopp, Ph.D., scientific director of the Henry Ford Neuroscience Institute at Henry Ford Hospital, won the 2014 Abraham White Distinguished Science Award for his discovery of the role of a protein in the treatment of brain injuries and neurodegenerative diseases. [More]
SLU researcher receives $608,376 grant to design better clinical treatments for multiple sclerosis

SLU researcher receives $608,376 grant to design better clinical treatments for multiple sclerosis

Saint Louis University researcher Daniel Hawiger, M.D., Ph.D., has been awarded $608,376 from the National Multiple Sclerosis Society to gain a better understanding of how the autoimmune process that causes multiple sclerosis (MS) may be stopped or slowed down. [More]
New subcellular mechanism identified for fast transmission in basket cells of the brain

New subcellular mechanism identified for fast transmission in basket cells of the brain

In his third major research paper since December 2013, IST Austria Professor Peter Jonas together with his collaborator, postdoc Hua Hu, identifies a new subcellular mechanism for reliable, fast transmission in the so-called basket cells of the brain. [More]
Treatment with natalizumab in patients with MS appears linked with JC virus infection

Treatment with natalizumab in patients with MS appears linked with JC virus infection

Treatment with natalizumab in patients with multiple sclerosis (MS) appears linked with JC virus (JCV) infection, which can lead to a rare and often fatal demyelinating disease of the central nervous system called progressive multifocal leukoencephalopathy (PML) that destroys the myelin that protects nerve cells. [More]
Researchers identify new type of regulatory blood cells that can combat brain inflammation

Researchers identify new type of regulatory blood cells that can combat brain inflammation

Hyperactivity of our immune system can cause a state of chronic inflammation. If chronic, the inflammation will affect our body and result in disease. In the devastating disease multiple sclerosis, hyperactivity of immune cells called T-cells induce chronic inflammation and degeneration of the brain. Researchers at BRIC, the University of Copenhagen, have identified a new type of regulatory blood cells that can combat such hyperactive T-cells in blood from patients with multiple sclerosis. By stimulating the regulatory blood cells, the researchers significantly decreased the level of brain inflammation and disease in a biological model. [More]
Leicester research reveals how noise damages hearing system

Leicester research reveals how noise damages hearing system

A research team investigating tinnitus, from the University of Leicester, has revealed new insights into the link between the exposure to loud sounds and hearing loss. [More]
Chronic stress generates long-term changes in brain that lead to mental problems

Chronic stress generates long-term changes in brain that lead to mental problems

University of California, Berkeley, researchers have shown that chronic stress generates long-term changes in the brain that may explain why people suffering chronic stress are prone to mental problems such as anxiety and mood disorders later in life. [More]
Researchers identify protein that promotes growth of brain cells damaged by MS

Researchers identify protein that promotes growth of brain cells damaged by MS

Vittorio Gallo, PhD, Director of the Center for Neuroscience Research at Children's National Health System, and other researchers have found a "potentially novel therapeutic target" to reduce the rate of deterioration and to promote growth of brain cells damaged by multiple sclerosis (MS). Current therapies can be effective in patients with relapsing MS, but have little impact in promoting tissue growth. [More]
Positive correlation between white matter quality and addition and multiplication proficiency

Positive correlation between white matter quality and addition and multiplication proficiency

A new study led by Professor Bert De Smedt (Faculty of Psychology and Educational Sciences, KU Leuven) has found that healthy 12-year-olds who score well in addition and multiplication have higher-quality white matter tracts. [More]
Myelin Repair Foundation enters into agreement with NIH to assess MRF-008 for multiple sclerosis

Myelin Repair Foundation enters into agreement with NIH to assess MRF-008 for multiple sclerosis

The Myelin Repair Foundation today announced it has entered a Cooperative Research and Development Agreement with the National Institutes of Health to assess MRF-008, as a potential therapeutic for multiple sclerosis. This CRADA will facilitate collaboration between the MRF and National Institute of Neurological Disorders and Stroke at the NIH Clinical Center to study MRF-008, a drug identified by the MRF as a potential neuroprotective therapeutic to enhance repair in multiple sclerosis patients. [More]
FAMPYRA now available in Ireland for symptomatic treatment of walking impairment in MS patients

FAMPYRA now available in Ireland for symptomatic treatment of walking impairment in MS patients

Biogen Idec today announced that FAMPYRA (prolonged-release fampridine tablets) has been made available in Ireland for the symptomatic treatment of walking impairment in adults with Multiple Sclerosis. FAMPYRA is a prescription drug and is licensed for use in all types of the disease, including the progressive forms. FAMPYRA is available by way of retail pharmacy on a private payment basis. [More]